SLV 314

Drug Profile

SLV 314

Alternative Names: SLV-314

Latest Information Update: 17 Aug 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Solvay
  • Class Antipsychotics; Benzoxazines; Indoles
  • Mechanism of Action Dopamine D2 receptor antagonists; Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Bipolar disorders; Schizophrenia

Most Recent Events

  • 05 Mar 2007 Phase-I clinical trials in Bipolar disorders in USA (PO)
  • 05 Mar 2007 Phase-I clinical trials in Schizophrenia in European Union (PO)
  • 05 Mar 2007 Phase-I clinical trials in Schizophrenia in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top